Sign Up to like & get
recommendations!
2
Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1245
Abstract: This study compared the pharmacokinetic and safety profiles between a new generic and a branded reference product of 10-mg ezetimibe (EZE) tablets in 24 healthy Japanese male volunteers under fasting conditions, obtaining sufficient evidence for…
read more here.
Keywords:
reference;
fasting conditions;
concentration;
bioequivalence ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1249
Abstract: A single-dose, open-label, randomized, two-period crossover-design study was conducted to evaluate the bioequivalence of the reference and test formulations of mifepristone tablets. Each subject was randomized at the beginning to receive a 25-mg tablet of…
read more here.
Keywords:
mifepristone tablets;
period;
fasting conditions;
bioequivalence ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.445
Abstract: This study aimed to investigate the bioequivalence of 2 formulations of gliclazide modified‐release tablets 60 mg in 48 healthy Caucasian volunteers under fasting conditions. A test product, Gliclazide MR (Ranbaxy Laboratories Limited, now Sun Pharmaceutical…
read more here.
Keywords:
healthy caucasian;
bioequivalence;
crossover;
fasting conditions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Medical Sciences"
DOI: 10.7150/ijms.80396
Abstract: Chewing is beneficial not only for digestion and absorption of food, but also for various physiological functions, such as cognition and immunity. In this study, the effect of chewing on hormonal changes and the immune…
read more here.
Keywords:
antibody production;
fasting conditions;
production;
conditions mice ... See more keywords